文献速递其他结缔组织病

抗核含缬酪肽蛋白样自身抗体与系统性硬化症钙质沉着及更高癌症风险相关

Anti-nuclear valosin-containing protein-like autoantibody is associated with calcinosis and higher risk of cancer in systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

本研究通过新型蛋白免疫沉淀法在307例系统性硬化症患者中发现核含缬酪肽蛋白样(NVL)为新自身抗体靶点,抗NVL阳性患者钙质沉着(100% vs 18.9%)和癌症(66.7% vs 8.9%)患病率更高,并与同步癌症相关(OR=16.3)。

要点

  • 在已知系统性硬化症特异性抗体阴性的患者中,蛋白免疫沉淀法可检出抗NVL抗体。
  • 抗NVL阳性患者钙质沉着患病率为100%,显著高于阴性患者的18.9%。
  • 抗NVL阳性患者癌症患病率为66.7%,显著高于阴性患者的8.9%,同步癌症OR=16.3。

核心结论

  • 在商业检测和RNA免疫沉淀均阴性的系统性硬化症患者中,通过新型蛋白免疫沉淀法鉴定出NVL为新自身抗体靶点,抗NVL抗体定义了一个以钙质沉着和癌症为特征的新临床表型。

研究设计与样本

  • 研究纳入307例系统性硬化症患者,所有患者均行HEp-2细胞间接免疫荧光检测抗核抗体,系统性硬化症特异性抗体采用商业免疫印迹、化学发光免疫分析及传统RNA免疫沉淀评估。
  • 对上述所有抗体均阴性的51例患者进一步行非放射性蛋白免疫沉淀检测,SDS-PAGE检测到的蛋白条带经质谱分析并通过蛋白质印迹确认;另对56例间接免疫荧光呈核仁型的患者行蛋白免疫沉淀-蛋白质印迹检测。

主要发现

  • 5例接受蛋白免疫沉淀检测的患者在SDS-PAGE上显示110-115kDa分子量条带,间接免疫荧光呈均质核仁型,质谱鉴定为核含缬酪肽蛋白样(NVL)。
  • 通过蛋白免疫沉淀-蛋白质印迹额外检出1例阳性患者。
  • 与其余101例阴性患者相比,抗NVL阳性患者钙质沉着患病率更高(100% vs 18.9%,P < 0.001)。
  • 与其余101例阴性患者相比,抗NVL阳性患者癌症患病率更高(66.7% vs 8.9%,P = 0.002),尤其与同步癌症相关(OR = 16.3;P = 0.024)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic sclerosis (SSc)-specific autoantibodies allow the diagnosis and predict the prognosis of SSc patients with different clinical characteristics. The aim of this study was to describe new SSc-related autoantibodies by a novel protein immunoprecipitation (IP) assay. METHODS: Serum samples and clinical data were collected from 307 SSc patients. Antinuclear autoantibodies were tested in all patients by indirect immunofluorescence (IIF) on HEp-2 cells. SSc-specific autoantibodies were evaluated with a commercial immunoblot and chemiluminescence immunoassay, and traditional RNA-IP. Patients negative for all these autoantibodies (n = 51) were further tested with a non-radioactive protein IP assay. Protein bands detected on SDS-PAGE were then analysed by mass spectrometry (MS) and confirmed by western blot (WB). Additional 56 patients with nucleolar pattern by IIF were tested by protein IP-WB. RESULTS: Five patients who underwent protein IP testing showed a 110-115kDa molecular weight band on SDS-PAGE and a homogeneous nucleolar pattern by IIF. MS identified the bands as nuclear valosin-containing protein-like (NVL). An additional positive patient was detected by IP-WB. As compared with the remaining 101 negative patients, anti-NVL positive patients showed a greater prevalence of calcinosis (100% vs 18.9%, P < 0.001), and cancer (66.7% vs 8.9%, P = 0.002), with a particular association with synchronous cancer (OR = 16.3; P = 0.024). CONCLUSION: We identified NVL as a new autoantibody target by a novel protein IP assay in SSc patients with a homogeneous nucleolar IIF pattern, testing negative for all known SSc-specific autoantibodies by commercial assays and RNA IP. Anti-NVL identifies a new clinical phenotype, characterized by calcinosis and cancer.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Perurena-Prieto J, Viñas-Giménez L, Sanz-Martínez MT, et al. Anti-nuclear valosin-containing protein-like autoantibody is associated with calcinosis and higher risk of cancer in systemic sclerosis. Rheumatology (Oxford). 2024. PMID: 37769243. doi:10.1093/rheumatology/kead520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。